HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter J Lenting Selected Research

Neutralizing Antibodies

2/2019Antibodies in the Treatment of Haemophilia A-A Biochemical Perspective.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter J Lenting Research Topics

Disease

25Hemorrhage
04/2024 - 01/2004
21Thrombosis (Thrombus)
04/2024 - 09/2003
18Hemophilia A (Haemophilia)
05/2024 - 04/2005
12von Willebrand Diseases (von Willebrand's Disease)
01/2023 - 11/2005
8Thrombocytopenia (Thrombopenia)
10/2023 - 08/2007
7Thrombotic Thrombocytopenic Purpura
04/2024 - 11/2005
7Type 2 von Willebrand Disease
12/2019 - 11/2005
6Inflammation (Inflammations)
04/2024 - 02/2016
3Aortic Valve Stenosis (Aortic Stenosis)
07/2016 - 03/2015
2Thrombotic Microangiopathies
01/2024 - 04/2008
2Neoplasms (Cancer)
01/2022 - 01/2013
2COVID-19
12/2020 - 11/2020
2Vascular System Injuries
01/2019 - 10/2016
2Body Weight (Weight, Body)
11/2017 - 08/2009
2Aortic Valve Insufficiency (Aortic Regurgitation)
07/2016 - 03/2015
2Infections
02/2010 - 04/2007
1Ischemia
04/2024
1Wounds and Injuries (Trauma)
12/2023
1Colitis
11/2023
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2023
1Mucopolysaccharidoses
01/2023
1Hyperplasia
01/2022
1Virus Diseases (Viral Diseases)
01/2022
1Brain Ischemia (Cerebral Ischemia)
01/2021
1Reperfusion Injury
01/2021
1Paraproteinemias (Monoclonal Gammopathy)
01/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2021
1Thromboinflammation
01/2021
1Ischemic Stroke
01/2021
1Hypertension (High Blood Pressure)
11/2020
1Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2020
1Hemophilia B (Haemophilia B)
12/2019
1Heart Valve Diseases (Valvular Heart Disease)
12/2019

Drug/Important Bio-Agent (IBA)

43von Willebrand FactorIBA
04/2024 - 03/2004
11Factor VIII (Coagulation Factor VIII)IBA
05/2024 - 05/2003
8AntibodiesIBA
01/2021 - 01/2004
8Proteins (Proteins, Gene)FDA Link
01/2020 - 08/2004
6emicizumabIBA
12/2023 - 01/2019
6ThrombinFDA Link
11/2023 - 08/2017
6Hemostatics (Antihemorrhagics)IBA
01/2023 - 04/2012
5Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
05/2024 - 03/2013
5thiamine triphosphorate (TTP)IBA
04/2024 - 11/2005
5Glycoproteins (Glycoprotein)IBA
01/2022 - 03/2004
5AntigensIBA
01/2021 - 03/2007
4Factor X (Stuart Factor)IBA
04/2024 - 02/2016
4Blood Coagulation Factors (Coagulation Factor)IBA
05/2023 - 04/2005
4CollagenIBA
03/2013 - 03/2008
3fitusiranIBA
04/2024 - 12/2020
3AntithrombinsIBA
05/2023 - 01/2020
3Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2022 - 08/2017
3ferric chlorideIBA
08/2017 - 09/2008
3Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)IBA
01/2015 - 01/2009
2Biomarkers (Surrogate Marker)IBA
01/2024 - 11/2020
2caplacizumabIBA
01/2022 - 10/2020
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2022 - 03/2011
2Adenosine Diphosphate (ADP)IBA
01/2022 - 07/2016
2Fibrinogen (Factor I)FDA Link
01/2022 - 11/2020
2lipoprotein-associated coagulation inhibitor (TFPI)IBA
12/2020 - 01/2020
2Oxygen (Dioxygen)IBA
12/2020 - 11/2020
2Single-Domain AntibodiesIBA
01/2020 - 01/2017
2SerpinsIBA
01/2020 - 11/2019
2AnticoagulantsIBA
01/2020 - 11/2019
2IntegrinsIBA
01/2018 - 12/2013
2LigandsIBA
01/2015 - 08/2008
2Complementary DNA (cDNA)IBA
08/2008 - 03/2008
2LDL Receptors (LDL Receptor)IBA
08/2004 - 05/2003
1Metalloproteases (Metalloproteinases)IBA
05/2024
1DisintegrinsIBA
05/2024
1ThrombospondinsIBA
05/2024
1Interleukin-1 (Interleukin 1)IBA
04/2024
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
04/2024
1FibrinolysinFDA Link
01/2024
1EnzymesIBA
01/2023
1AutoantigensIBA
01/2023
1Antifibrinolytic Agents (Antifibrinolytics)IBA
05/2022
1Protamines (Protamine Sulfate)FDA Link
01/2022
1Heparin (Liquaemin)FDA LinkGeneric
01/2022
1OsteoprotegerinIBA
01/2022
1EpitopesIBA
01/2021
1SuspensionsIBA
01/2021
1Member 2 Protein Solute Carrier Family 44IBA
01/2021
1C-Reactive ProteinIBA
11/2020
1Factor VIIa (Activated Factor VII)IBA
01/2020
1prothrombin complex concentrates (PPSB)IBA
01/2020
1Anti-Idiotypic AntibodiesIBA
01/2020
1Protein CIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1Factor IXa (Coagulation Factor IXa)IBA
01/2020
1cancer procoagulantIBA
12/2019
1Thromboplastin (Tissue Factor)IBA
11/2019
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
11/2019
1Peptide Hydrolases (Proteases)FDA Link
11/2019

Therapy/Procedure

9Therapeutics
05/2024 - 01/2013
6Surgical Instruments (Clip)
01/2022 - 01/2017
3Lasers (Laser)
04/2024 - 08/2017
2Transcatheter Aortic Valve Replacement
07/2016 - 03/2015
2Heart-Assist Devices
01/2016 - 03/2015
1Extracorporeal Membrane Oxygenation
10/2023
1Ligation
01/2022